| 5MY6 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | GOL, NAG | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | 131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment., D'Huyvetter M, De Vos J, Xavier C, Pruszynski M, Sterckx YGJ, Massa S, Raes G, Caveliers V, Zalutsky M, Lahoutte T, Devoogdt N, Clin Cancer Res. 2017 Jul 27. pii: clincanres.0310.2017. doi:, 10.1158/1078-0432.CCR-17-0310. PMID:28751451 | ||||||||||||||
| Data retrieval |
![]() |
| View 5MY6 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |